Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biopharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:ABC
- CUSIP: N/A
- Web: www.abcam.com/
Capitalization:- Market Cap: £2.19 billion
- Outstanding Shares: 202,199,000
Average Prices:- 50 Day Moving Avg: GBX 1,002.64
- 200 Day Moving Avg: GBX 923.89
- 52 Week Range: GBX 714 - GBX 1,090
P/E:- Trailing P/E Ratio: 54.32
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: £195.56 million
- Price / Sales: 11.18
- Book Value: GBX 1.44 per share
- Price / Book: 7.51
Dividend:
Profitability:- EBIDTA: £67.65 million
- Net Margins: 19.33%
- Return on Equity: 14.31%
- Return on Assets: 11.57%
Misc:- Average Volume: 423,891 shs.
Frequently Asked Questions for Abcam Plc (LON:ABC)
What is Abcam Plc's stock symbol?
Abcam Plc trades on the London Stock Exchange (LON) under the ticker symbol "ABC."
How often does Abcam Plc pay dividends? What is the dividend yield for Abcam Plc?
Abcam Plc declared a dividend on Monday, March 6th. Investors of record on Thursday, March 16th will be paid a dividend of GBX 2.83 per share on Thursday, April 13th. This represents a yield of 0.31%. The ex-dividend date is Thursday, March 16th. The official announcement can be viewed at this link. View Abcam Plc's Dividend History.
When will Abcam Plc make its next earnings announcement?
Where is Abcam Plc's stock going? Where will Abcam Plc's stock price be in 2017?
6 brokers have issued 12 month price objectives for Abcam Plc's stock. Their predictions range from GBX 680 to GBX 1,116. On average, they anticipate Abcam Plc's share price to reach GBX 900 in the next year. View Analyst Ratings for Abcam Plc.
Who are some of Abcam Plc's key competitors?
Some companies that are related to Abcam Plc include Anika Therapeutics (ANIK), Myovant Sciences Ltd (MYOV), Syros Pharmaceuticals (SYRS), Sinovac Biotech (SVA), ChemoCentryx (CCXI), Syndax Pharmaceuticals (SNDX), Strongbridge Biopharma PLC (SBBP), Fortress Biotech (FBIO), Mereo BioPharma Group PLC (MPH), Kamada (KMDA), Peregrine Pharmaceuticals (PPHM), MediWound (MDWD), Cardiome Pharma Corporation (CRME), Kadmon Holdings (KDMN), Vericel Corporation (VCEL), VIVUS (VVUS), Alimera Sciences (ALIM) and KalVista Pharmaceuticals (KALV).
Who are Abcam Plc's key executives?
Abcam Plc's management team includes the folowing people:
- Alan Thomas Hirzel, Chief Executive Officer, Executive Director
- Gavin Hilary James Wood, Chief Financial Officer, Executive Director
- Suzanne Elaine Smith, Chief Legal Officer, Company Secretary
- Jonathan Simon Milner Ph.D., Deputy Chairman of the Board
- Murray Edwin Hennessy, Non-Executive Chairman of the Board
- Mara Glickman Aspinall, Non-Executive Director
- Susan Elizabeth Harris, Non-Executive Director
- Louise A. V. C. Patten, Senior Independent Non-Executive Director
How do I buy Abcam Plc stock?
Shares of Abcam Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abcam Plc's stock price today?
One share of Abcam Plc stock can currently be purchased for approximately GBX 1,081.
MarketBeat Community Rating for Abcam Plc (LON ABC)MarketBeat's community ratings are surveys of what our community members think about Abcam Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Abcam Plc (LON:ABC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 4 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | GBX 900 |
Analysts' Ratings History for Abcam Plc (LON:ABC)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 7/27/2017 | Panmure Gordon | Reiterated Rating | Sell | |  |
| 7/27/2017 | Numis Securities Ltd | Reiterated Rating | Add | GBX 1,116 | |
| 6/27/2017 | Berenberg Bank | Initiated Coverage | Buy | GBX 1,100 | |
| 5/2/2017 | Stifel Nicolaus | Reiterated Rating | Hold | GBX 890 | |
| 3/27/2017 | J P Morgan Chase & Co | Boost Price Target | Neutral | GBX 678 -> GBX 864 | |
| 3/17/2017 | Peel Hunt | Reiterated Rating | Hold | GBX 750 | |
| 4/4/2016 | Royal Bank Of Canada | Initiated Coverage | Sector Performer | GBX 610 | |
| 11/2/2015 | Canaccord Genuity | Upgrade | Hold | GBX 432 | |
| 9/16/2015 | Investec | Reiterated Rating | Buy | | |
(Data available from 8/18/2015 forward)
Earnings History for Abcam Plc (LON:ABC)Earnings History by Quarter for Abcam Plc (LON ABC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 9/11/2017 | | | | | | | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Abcam Plc (LON:ABC)Current Year EPS Consensus Estimate: $60.67 EPS
Dividend History by Quarter for Abcam Plc (LON ABC)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/6/2017 | | GBX 2.83 | 0.31% | 3/16/2017 | 3/16/2017 | 4/13/2017 |
| 9/12/2016 | | GBX 6.56 | 0.83% | 11/10/2016 | 11/10/2016 | 12/2/2016 |
| 3/7/2016 | | GBX 2.35 | 0.38% | 3/17/2016 | 3/17/2016 | 4/15/2016 |
| 9/14/2015 | | GBX 5.92 | 0.99% | 11/12/2015 | 11/12/2015 | 12/4/2015 |
| 9/9/2014 | | GBX 5.62 | 1.31% | 11/6/2014 | 11/6/2014 | 11/28/2014 |
| 3/4/2014 | | GBX 2.13 | 0.5% | 3/19/2014 | 3/19/2014 | 4/18/2014 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Abcam Plc (LON:ABC)Insider Trades by Quarter for Abcam Plc (LON:ABC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/5/2017 | Mara G Aspinall | Insider | Buy | 2,700 | GBX 979 | £26,433 | |
| 3/22/2017 | Alan Thomas Hirzel | Insider | Buy | 6,000 | GBX 809 | £48,540 | |
| 3/20/2017 | Alan Thomas Hirzel | Insider | Buy | 6,000 | GBX 839 | £50,340 | |
| 12/8/2016 | Mara G Aspinall | Insider | Buy | 298 | GBX 786 | £2,342.28 | |
| 12/7/2016 | Alan Thomas Hirzel | Insider | Buy | 227 | GBX 792 | £1,797.84 | |
| 12/2/2016 | P. Warwick | Insider | Sell | 30,000 | GBX 808 | £242,400 | |
| 9/30/2016 | Louise Patten | Insider | Buy | 12,378 | GBX 836 | £103,480.08 | |
| 9/19/2016 | Milner,Jonathan Simon | Insider | Sell | 20,361 | GBX 820 | £166,960.20 | |
| 9/14/2016 | Ross,Michael | Insider | Buy | 954 | GBX 800 | £7,632 | |
| 11/11/2015 | Hirzel,Alan Thomas | Insider | Buy | 3,335 | GBX 580 | £19,343 | |
| 10/27/2015 | Iliffe,Jeffrey | Insider | Buy | 301 | GBX 599 | £1,802.99 | |
| 9/18/2015 | Hirzel,Alan Thomas | Insider | Buy | 4,000 | GBX 615 | £24,600 | |
| 3/26/2015 | Jonathan Simon Milner | Insider | Sell | 2,480,000 | GBX 465 | £11,532,000 | |
(Data available from 1/1/2013 forward)
Headline Trends for Abcam Plc (LON:ABC)
Latest Headlines for Abcam Plc (LON:ABC)
| Source: |
|
| Date | Headline |
|---|
 | Panmure Gordon Reaffirms Sell Rating for Abcam Plc (ABC)
www.americanbankingnews.com - July 27 at 11:21 AM |
| Abcam Plc (ABC) Given "Add" Rating at Numis Securities Ltd
www.americanbankingnews.com - July 27 at 10:53 AM |
| Abcam Plc (LON:ABC) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - July 24 at 10:56 AM |
| Abcam Plc (ABC) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 27 at 9:26 AM |
 | OraSure Technologies (OSUR) Names Mara Aspinall to Board
www.streetinsider.com - June 22 at 6:32 PM |
| Abcam Plc (ABC) Insider Mara G. Aspinall Buys 2,700 Shares
www.americanbankingnews.com - June 7 at 1:26 PM |
 | Protein Assays Market expected to reach USD 2.41 billion in 2022
www.prnewswire.com - June 6 at 3:19 PM |
| Allscripts Healthcare Solutions (MDRX) Appoints Mara Aspinall to Director
www.streetinsider.com - May 26 at 1:37 AM |
 | DIRECTOR DEALINGS: Abcam Finance Boss Gavin Wood Ups Interest
www.morningstar.co.uk - May 3 at 3:17 PM |
 | Abcam Plc – Value Analysis (LONDON:ABC) : May 1, 2017
finance.yahoo.com - May 2 at 5:28 AM |
| Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : April 28, 2017
finance.yahoo.com - April 28 at 3:05 PM |
| Abcam Plc (ABC) Stock Rating Reaffirmed by Panmure Gordon
www.americanbankingnews.com - April 20 at 7:37 PM |
 | Global Multiplex Assays Market Expected to Reach $5,720 Million by 2022 - Allied Market Research
www.bizjournals.com - April 20 at 3:15 PM |
| Immunohistochemistry (IHC) Market Size to Reach $3.1 Billion by 2025: Grand View Research, Inc.
finance.yahoo.com - April 11 at 8:30 AM |
| Abcam Plc (ABC) Stock Rating Reaffirmed by Stifel Nicolaus
www.americanbankingnews.com - April 8 at 7:20 PM |
| Abcam Plc : ABC-GB: Dividend Analysis : March 17th, 2017 (record date) : By the numbers : April 4, 2017
finance.yahoo.com - April 7 at 5:22 AM |
| Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : April 5, 2017
finance.yahoo.com - April 7 at 5:22 AM |
| Abcam Plc (ABC) PT Raised to GBX 864 at JPMorgan Chase & Co.
www.americanbankingnews.com - April 1 at 5:21 PM |
| Abcam Plc (ABC) PT Raised to GBX 864
www.americanbankingnews.com - March 31 at 3:56 AM |
| Abcam Plc (ABC) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 29 at 1:22 PM |
| Abcam Plc (ABC) Insider Alan Thomas Hirzel Purchases 6,000 Shares
www.americanbankingnews.com - March 24 at 10:08 AM |
| Abcam Plc (ABC) Earns Hold Rating from Peel Hunt
www.americanbankingnews.com - March 23 at 4:24 AM |
| Alan Thomas Hirzel Acquires 6,000 Shares of Abcam Plc (ABC) Stock
www.americanbankingnews.com - March 21 at 7:31 AM |
| Abcam Plc's (ABC) "Sell" Rating Reaffirmed at Panmure Gordon
www.americanbankingnews.com - March 20 at 12:27 PM |
| Peel Hunt Reiterates Hold Rating for Abcam Plc (ABC)
www.americanbankingnews.com - March 18 at 12:33 AM |
 | This biotech stock is already worth £1.7bn — is it still a buy?
uk.finance.yahoo.com - March 17 at 3:18 PM |
| Research Analysts’ Upgrades for March, 14th (ABCZY, ADHD, AMID, CELTF, CFFN, FLXN, FSS, FURCY, GDEN, GLP)
www.americanbankingnews.com - March 15 at 12:25 AM |
| Abcam PLC (ABCZY) Lifted to “Buy” at Zacks Investment Research
www.americanbankingnews.com - March 15 at 12:24 AM |
| Peel Hunt Reaffirms Hold Rating for Abcam Plc (ABC)
www.americanbankingnews.com - March 12 at 11:27 AM |
| Abcam Plc (ABC) Receives Neutral Rating from JPMorgan Chase & Co.
www.americanbankingnews.com - March 12 at 1:46 AM |
 | BRIEF-Abcam H1 pretax profit rises
www.businessinsider.com - March 7 at 3:16 PM |
 | UPDATE 2-UK Stocks-Factors to watch on March 6 - Reuters
www.reuters.com - March 6 at 10:09 AM |
| Can these £1.7bn AIM growth stocks double again?
uk.finance.yahoo.com - March 6 at 10:09 AM |
| $47.08 Billion Cell Analysis Market - Global Forecast to 2023 - Research and Markets
finance.yahoo.com - February 18 at 9:24 AM |
| Octopus AIM VCT 2 plc : Final Results - Yahoo Finance - Yahoo Finance
finance.yahoo.com - February 14 at 3:21 PM |
Abcam Plc (ABC) Chart for Friday, August, 18, 2017
